Correlation Between Innovator IBD and 19123MAF0

Can any of the company-specific risk be diversified away by investing in both Innovator IBD and 19123MAF0 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innovator IBD and 19123MAF0 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Innovator IBD 50 and CCEP 15 15 JAN 27, you can compare the effects of market volatilities on Innovator IBD and 19123MAF0 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innovator IBD with a short position of 19123MAF0. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innovator IBD and 19123MAF0.

Diversification Opportunities for Innovator IBD and 19123MAF0

-0.32

Correlation Coefficient

Innovator IBD  19123MAF0

Very good diversification

The 3 months correlation between Innovator and 19123MAF0 is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Innovator IBD 50 and CCEP 15 15 JAN 27 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CCEP 15 15 and Innovator IBD is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innovator IBD 50 are associated (or correlated) with 19123MAF0. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CCEP 15 15 has no effect on the direction of Innovator IBD i.e., Innovator IBD and 19123MAF0 go up and down completely randomly.

Pair Corralation between Innovator IBD and 19123MAF0

Given the investment horizon of 90 days Innovator IBD 50 is expected to under-perform the 19123MAF0. In addition to that, Innovator IBD is 12.53 times more volatile than CCEP 15 15 JAN 27. It trades about -0.03 of its total potential returns per unit of risk. CCEP 15 15 JAN 27 is currently generating about 0.11 per unit of volatility. If you would invest  9,325  in CCEP 15 15 JAN 27 on December 30, 2024 and sell it today you would earn a total of  63.00  from holding CCEP 15 15 JAN 27 or generate 0.68% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	50.0%
Values	Daily Returns

Innovator IBD 50  vs.  CCEP 15 15 JAN 27

Innovator IBD 50

Risk-Adjusted Performance

Very Weak

Over the last 90 days Innovator IBD 50 has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Innovator IBD is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

CCEP 15 15

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in CCEP 15 15 JAN 27 are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, 19123MAF0 is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Innovator IBD and 19123MAF0

The main advantage of trading using opposite Innovator IBD and 19123MAF0 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innovator IBD position performs unexpectedly, 19123MAF0 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 19123MAF0 will offset losses from the drop in 19123MAF0's long position.

The idea behind Innovator IBD 50 and CCEP 15 15 JAN 27 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.